2023 Annual Report on Form 10-K and 2024 Proxy Statement 5.3 MB, 2022 Annual Report on Form 10-K and 2023 Proxy Statement 12.5 MB, 2021 Annual Report

11/04/24, 10-Q · Quarterly report which provides a continuing view of a company's financial position. Quarterly Filings. 0001551152-24- ...

AbbVie Inc. ABBV on NYSE. This company's Exchange Act registration has ... November 4, 2024 - 10-Q: Quarterly report for quarter ending September 30, 2024 ...

20 февр. 2024 г. · The price-setting process will conclude by August 1, 2024, and on September 1, 2024, the CMS will publish prices that will be applicable to the ...

The main purpose of Abbvie 10K is to help investors understand the financial performance of Abbvie so that they can make informed decisions. 2024-02-20, AbbVie ...